A Study to Evaluate YH001 in Subjects With Advanced Solid Tumors

NCT04699929 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: YH001

Sponsor

Eucure (Beijing) Biopharma Co., Ltd